Photo: Jeff MillerBruce Christensen As public health officials on the East Coast keep an eye out for anything that hints of West Nile virus this year, researchers at the University of Wisconsin, Madison, are hoping their ongoing basic research will help put a monkey wrench into the genetic machinery that lets mosquitoes transmit deadly and debilitating illnesses. Bruce Christensen, professor of animal health and biomedical sciences, and his team of 15 researchers, technicians, and undergraduates
| Photo: Jeff Miller |
 Bruce Christensen |
For instance, malaria, which is caused by such protozoan parasites as Plasmodium falciparum and Plasmodium vivax, kills nearly three million people annually, according to the United Nations. Elephantiasis, which is caused by nematodes injected into human hosts, currently infects more than 100 million people. Major drivers of this research are the environmental and health concerns that ...
Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.
View this Issue
Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro models for neurological research and drug discovery.
Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.
In this webinar, Linghua Wang and Jeremy Goecks will talk about technology that enables new approaches for a better understanding of tumors on a cellular, spatial, and environmental level.
Explore how researchers use organoids to understand tissue regeneration and develop novel therapies.
Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery. Company also announces key accreditations in recognition of excellence in data security, AI innovation, and commitment to continuous improvement.
Partnership complements Sapient’s mass spectrometry-based proteomics services, extends multi-omics solutions, and will enable development of NULISAseq™ assays under regulated guidance
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of Vericheck ddPCR™ Empty-Full Capsid Kits for adeno-associated virus (AAV) serotypes 2 and 8, enabling determination of capsid titer, genome titer, and percentage of full capsids in purified or unpurified (crude lysate) samples.
Tailored nucleic acid extraction and amplification methods help scientists overcome the challenges of detecting Mycoplasma contamination in advanced therapy medicinal products.
